Stocks
Single names, sectors, valuations and the trades behind the tape, explained in plain language.
UBS Says Boston Scientific's Stock Overlooks Upcoming Heart Device Pipeline
UBS says Boston Scientific's stock has fallen enough that the market is pricing in sales declines through 2029. But the bank sees high-singl
Seer shareholders sweeten buyout offer to $2.55 per share with contingent value right
Activist shareholders Bradley Radoff and Michael Torok have increased their buyout offer for Seer to $2.55 per share. The new non-binding bi
Diana Shipping Questions Genco's Valuation Shift Amid Proxy Fight
Diana Shipping claims Genco's fleet value dropped $50 million since June, per VesselsValue. Diana questions why Genco changed its valuation
RBC warns Hershey may miss Q2 revenue on weak candy sales
RBC Capital Markets warns Hershey may miss second-quarter revenue expectations due to weaker North American candy sales. The bank cites reta
Ocado drops £190m claim against M&S, shifts focus to growth
Ocado has dropped its claim for a roughly £190 million payout from Marks & Spencer tied to their Ocado Retail joint venture. The partners wi
Coca-Cola loses India market share as Diet Coke demand surges 10x
Coca-Cola lost market share in India in the second quarter, hurt by a lack of mid-priced pack sizes and rising aluminum costs. Meanwhile, Di
Elevance Health insiders buy shares as CEO and chair add to holdings
Elevance Health CEO Gail Boudreaux bought $1 million of stock on July 17, and chair Ramiro Peru made his first purchase since 2008. Insider
S&P Global expands into African credit ratings and data center research with two acquisitions
S&P Global is buying majority stakes in two specialized information businesses: Pan-African credit rater Agusto & Co. and data center resear
Incyte raises 2026 outlook after Opzelura Medicaid rebate deal
Incyte raised its 2026 revenue outlook after a June deal with CMS altered Medicaid rebate calculations for its eczema drug Opzelura. The cha
Pentair sales drop 17% on pool destocking, but $1.4B Taco deal stays on track
Pentair reported a 17% drop in second-quarter sales as pool distributors worked through excess inventory. The company reaffirmed its full-ye
GSK slashes £1.9 billion in costs to fuel drug pipeline and chase £40 billion revenue goal
GSK has announced a £1.9 billion cost-cutting plan over three years. The savings will fund late-stage drug development as the company aims f
UPM-Kymmene slides on weak pulp prices, but Berenberg lifts target
Finnish forest-products company UPM-Kymmene slid after a tough second quarter. Berenberg kept a hold rating but raised its price target to €